a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.

NPH insulin, or neutral protamine Hagedorn insulin, is a type of intermediate-acting insulin used by people with diabetes. It works similarly to the body's natural insulin production but has a longer ...

In the early years, NASA launched many probes to the moon, not to mention blood sugar spreadsheet free blood sugar and vision blurred can white wine lower blood sugar fasting blood sugar of 138 can an ...

28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly) 28 days Prescribing information NPH, human insulin isophane suspension (rDNA origin) Novolin N vial (Novo ...

For millions of Americans living with diabetes, the rising cost of insulin has become an incredibly serious burden. With prices for a single vial of insulin in the U.S. soaring from $35 to over $ ...

The average wholesale prices of the originator insulin are around $329 per vial and $510 for five pens, according to Civica, which says it will start clinical trials of the biosimilars this year ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Medicare will cover a portion of the cost of your insulin pump if you have a doctor’s prescription and meet the following criteria: You complete a comprehensive diabetes education program ...

Objectives To evaluate structure, documentation, treatment quality of a new implemented standardised insulin chart in adult medical inpatient wards at a university hospital. Design A before–after ...

Department of Phase I Clinical Trial Ward, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China Objective: The aim of the study was to investigate the different extent of ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...